Saltar al contenido
Merck

Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression.

The Journal of experimental medicine (2001-08-22)
S Landmann, A Mühlethaler-Mottet, L Bernasconi, T Suter, J M Waldburger, K Masternak, J F Arrighi, C Hauser, A Fontana, W Reith
RESUMEN

Cell surface expression of major histocompatibility complex class II (MHCII) molecules is increased during the maturation of dendritic cells (DCs). This enhances their ability to present antigen and activate naive CD4(+) T cells. In contrast to increased cell surface MHCII expression, de novo biosynthesis of MHCII mRNA is turned off during DC maturation. We show here that this is due to a remarkably rapid reduction in the synthesis of class II transactivator (CIITA) mRNA and protein. This reduction in CIITA expression occurs in human monocyte-derived DCs and mouse bone marrow-derived DCs, and is triggered by a variety of different maturation stimuli, including lipopolysaccharide, tumor necrosis factor alpha, CD40 ligand, interferon alpha, and infection with Salmonella typhimurium or Sendai virus. It is also observed in vivo in splenic DCs in acute myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalitis. The arrest in CIITA expression is the result of a transcriptional inactivation of the MHC2TA gene. This is mediated by a global repression mechanism implicating histone deacetylation over a large domain spanning the entire MHC2TA regulatory region.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
trans-2-Bromovinylboronic acid MIDA ester, technical grade
Número de referencia del producto (SKU)
Tamaño de envase
Disponibilidad
Precio
Cantidad